These enzymes, including diacylglycerol acyltransferase, stearoyl-CoA desaturase, fatty acid synthase, ketohexokinase, and acetyl-CoA carboxylase, have been explored as potential therapeutic weapons against NAFLD. The gene discussed is SCD; the disease is metabolic dysfunction-associated steatotic liver disease.